TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
COMMENT
The problem/question with the lifecos is they have to set aside so much capital they are caught in the actuarial problem of the spread between the bond market and their payout schedules on the policies they have written. As long as the bond market stays down at his very low interest rates, it is very hard for these guys. There is probably a trade here, but for the longer pull there are better places with higher yields.
COMMENT
On the plus side, they are making tremendous penetration in Asia selling life insurance. Trading at less than Book Value per share. Probably oversold. All of the insurance companies have the problem that they are reinvesting insurance premiums at record low interest rates, which will continue for at least another 2 years. Life insurers make half their money by investing premiums in bond markets and paying out claims as they come in.
TOP PICK
This is a stock that no longer seems to get any respect, yet over the last 2 years, management have done a great deal to de-risk the company, hedge the exposure to interest rates and equity markets. Have also redesigned a lot of their product mix, which makes him less risky than a lot of their previous products. Continuing to expand on a global basis.
SELL
(Market Call Minute) Business model will not come back strong any time soon.
BUY ON WEAKNESS
Don’t consider selling it. Didn’t like the preferred issue recently. Pays a good dividend. A Company he is watching quite closely. Longer term MFC could do well, but he would like to see it cheaper.
SHORT
Right now it looks like a Short as it has broken through a support level.
HOLD
If the current rally continues, this company will more than fully participate. Wouldn't commit new money to it but would continue to hold it. Prefers the Canadian banks against the lifecos.
DON'T BUY
Doesn't like this stock. Earnings are going the wrong way.
DON'T BUY
As being a tough performer. Insurance companies are having a hard time. There are 2 things to look at. 1) Do they have growth in their product sales? This company has had some challenges. 2) How do they do on their equity portfolios? The equity market has been wildly volatile. He would steer clear of insurance companies.
SELL
In a RRIF account. Should he sell? They continued to guide lower on the reserves that they need to come up with. Very large business in China and India. Don't let registered stocks influence whether you sell or not.
HOLD
Management, over the last few years, has taken great strides in de-risking this company. Sensitivity to equity markets and interest rates is a lot less than what it was in 2008. Has also built up their capital.
DON'T BUY
Hit a 52 week low today. Earnings expectations are declining on this and other insurance companies. Below the 52 week average.
DON'T BUY
Doesn't own any of the insurance companies. They fund their liabilities through their investments. With equity markets being volatile and interest rates low, results have been pretty bad. These are a leveraged bet on the capital market. You are better off with banks because you at least get better dividends and more safety.
DON'T BUY
Insurance company invests life-premiums into bonds. Long bond yields are at record lows making it very difficult for them to make money on their portfolios. This copy is selling more life insurance in Asia and have mostly hedged their exposure to the stock market but difficult to see any buoyant prospects for insurance companies when the bond yields are so low.
DON'T BUY
Had a breakdown in 2008 and has been in a downtrend for the past 3 years. Has formed any kind of a base yet.
Showing 1,246 to 1,260 of 2,281 entries